FOXO4-DRI vs Glutathione
A side-by-side research comparison of FOXO4-DRI and Glutathione across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | FOXO4-DRI | Glutathione |
|---|---|---|
| Full name | FOXO4-D-Retro-Inverso Peptide (Senolytic) | L-Glutathione (Reduced) |
| Category | Anti-Aging | Anti-Aging |
| Status | Research compound | Supplement / Injectable |
| Mechanism | Competitively disrupts FOXO4 sequestration of p53 in senescent cells, releasing p53 to trigger intrinsic apoptosis selectively in cells relying on this survival mechanism. | Directly neutralizes free radicals, regenerates vitamins C and E, supports phase II liver detoxification, maintains cellular redox balance, and protects mitochondrial DNA. |
| Molecular weight | ~4,500 Da | 307.32 Da |
| Half-life | 12-24 hours (D-amino acid stability) | ~1.5-2 hours (IV/IM) |
| Bioavailability | Moderate (SubQ) | ~95% injectable; low oral (~3%) |
| Typical dose | 5-10 mg/kg (animal studies) | 200-600 mg |
| Frequency | 3x per week for 3 weeks | 1-3x per week |
| Route | Subcutaneous | IV push, IM injection, or nebulized |
FOXO4-DRI reported benefits
- Selective senescent cell elimination
- Potential aging reversal
- Improved tissue function
- Reduced inflammatory burden
- Hair regrowth (mice)
Glutathione reported benefits
- Powerful antioxidant protection
- Liver detoxification support
- Skin brightening
- Immune system support
- Anti-aging cellular protection
- Heavy metal chelation
Related comparisons
Research and educational reference only. Not medical advice.